gained weight on semaglutide Ozempic Rebound Is Real: Doctor Says Gain Can Be 'Devastating' After Stopping Weight Change With Semaglutide

While tirzepatide's cardiovascular outcomes data are still emerging, its dual incretin action offers a therapeutic profile for metabolic disease management

Key clinical wins : In 2024, Lilly announced new clinical trial results (e.g., further cardiovascular outcome benefits with tirzepatide), which have bolstered prescriber confidence

Billing: Immediately, the providers screen shows PA Request: Submitted with a reference ID

These benefits support their role as an alternative or adjunct to metformin, especially when weight loss is a primary treatment goal

Christian Hlscher, cofounder and chief scientific officer of Kariya Pharmaceuticals and a professor of neuroscience at the Henan University of Chinese Medicine, asked Drucker about the data that showed that tirzepatide and semaglutide have no effect in the mouse model of Alzheimers disease

doi:10.1038/s41430-018-0348-y [30] Vondra K, Vrbikova J, Dvorakova K